PAVM vs TROW · rev $55.0K vs P/E 12, rev $3.76B
PAVmed Inc (PAVM) versus T. Rowe Price Group Inc (TROW) — a side-by-side from cached financials, not a winner call.
PAVmed Inc (PAVM) is a medical devices company listed on NASDAQ.
T. Rowe Price Group Inc (TROW) is a asset management company listed on NASDAQ.
Latest reported PAVM revenue for 2026-06-30 was $55.0K. Net income was -$5.4M. PAVM currently screens at market cap $35.7M.
Latest reported TROW revenue for 2026-06-30 was $3.76B. Net income was $1.13B. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
PAVM currently screens at market cap $35.7M. TROW currently screens at market cap $23.17B and trailing P/E 11.6.
Not investment advice. Open the PAVM and TROW stock pages for the full models.
Not investment advice.